Quadriceps Muscle AtrophyNCT05768022
Origin to Insertion Kinesio Tapping vs Non-Directional Kinesio Tapping on Quadriceps Peak Torque
A study testing Cura Kensio-tapping in people with Quadriceps Muscle Atrophy, run by University of Jazan at 1 site in Saudi Arabia.
Trial summary
This study was conducted to investigate the effect of kinesio tapping on electrical activity and peak torque of quadriceps during concentric and eccentric muscle contraction were carried out in the motion analysis Laboratory. Read more about this study
- Who is it for?
- Ages 22 to 30 yearsHealthy volunteers can take part
- Conditions the study is for
- Quadriceps Muscle Atrophy
- What is being tested?
- Cura Kensio-tapping
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 200 participants
- Where
- 1 siteSaudi Arabia
- Study dates
- 1 Feb 2023to 5 Mar 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 22 to 30 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Age must be ranged from 22-30 years.
- Body mass index must be ranged from 20-24.9 kg/m².
Who cannot join
- Knee or quadriceps disorders preventing physical stress.
- Cardiovascular or neurological problems.
- Athletic subjects.
- Smokers.
- Heavy caffeine intake subjects.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Origin to Insertion Kinesio Tapping vs Non-Directional Kinesio Tapping on Quadriceps Peak
This study was conducted to investigate the effect of kinesio tapping on electrical activity and peak torque of quadriceps during concentric and eccentric muscle contraction were carried out in the motion analysis Laboratory.
Read the detailed description
A Pretest posttest control group design was used to. Two hundred normal subjects of both sexes were recruited.
Subjects were randomly assigned into two groups of equal number.
- Cura Kensio-tapping group: consisted of 100 subjects (females and males) will receive kinesio taping from origin to insertion on the superficial muscles of Quadriceps femoris (vastus medialis (VM), vastus lateralis (VL), rectus femoris (RF).
- Placebo-Group: consisted of 100 subjects (females and males) will receive placebo kinesio taping across quadriceps.
- Conditions
- Quadriceps Muscle Atrophy
- Being tested
- Cura Kensio-tapping, placebo
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Cura Kensio-tappingOther
Cura tapes, a cotton strip with an acrylic adhesive. allows for unidirectional elasticity up to 60% beyond its resting length.
placeboOther
placebo taping
| Study group | Role | What they receive |
|---|---|---|
| Cura kinesio-taping | Experimental | 100 subjects (females and males) will receive kinesio taping from origin to insertion on the superficial muscles of Quadriceps femoris (VM,VL, RF). Receives: Other: Cura Kensio-tapping |
| Placebo | Placebo comparator | 100 subjects (females and males) will receive placebo kinesio-taping across quadriceps. Receives: Other: placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Peak Torque Measurement 1
The peak torque of quadriceps muscle of dominant lower limb was measured using Biodex system 830-200 Isokinetic dynamometer.
Measured: Before tapping.
Peak Torque Measurement 2
The peak torque of quadriceps muscle of dominant lower limb was measured using Biodex system 830-200 Isokinetic dynamometer.
Measured: After the application of tapping by 10 minutes
Peak Torque Measurement 3
The peak torque of quadriceps muscle of dominant lower limb was measured using Biodex system 830-200 Isokinetic dynamometer.
Measured: 24 hours after tapping.
Peak Torque Measurement 4
The peak torque of quadriceps muscle of dominant lower limb was measured using Biodex system 830-200 Isokinetic dynamometer.
Measured: 72 hours After tapping
Peak Torque Measurement 5
The peak torque of quadriceps muscle of dominant lower limb was measured using Biodex system 830-200 Isokinetic dynamometer.
Measured: 5 days after removal of tapping b
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Mar 2023
- Study start1 Feb 2023
- Primary completion26 Feb 2023
- Study completion5 Mar 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Quadriceps Muscle AtrophyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- A Pretest posttest control group
- Masking
- None (open label)
- Enrolment
- 200 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Jazan
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Mohamed Moustafa Mohamed Ahmed, University of Jazan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05768022
- Sponsor's protocol ID
- 91177
- Status last verified
- Mar 2023
- First submitted
- 18 Feb 2023
- Last updated
- 14 Mar 2023
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Mar 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Origin to Insertion Kinesio Tapping vs Non-Directional Kinesio Tapping on Quadriceps Peak
- ClinicalTrials.gov ID
- NCT05768022
- Acronym / sponsor ID
- 91177
- Conditions
- Quadriceps Muscle Atrophy
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 200 participants (actual)
- Lead sponsor
- University of JazanOther government
- Study start
- 1 Feb 2023 (actual)
- Primary completion
- 26 Feb 2023 (actual)
- Study completion
- 5 Mar 2023 (actual)
- First posted
- 14 Mar 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study was conducted to investigate the effect of kinesio tapping on electrical activity and peak torque of quadriceps during concentric and eccentric muscle contraction were carried out in the motion analysis Laboratory.
Detailed description
A Pretest posttest control group design was used to. Two hundred normal subjects of both sexes were recruited.
Subjects were randomly assigned into two groups of equal number.
- Cura Kensio-tapping group: consisted of 100 subjects (females and males) will receive kinesio taping from origin to insertion on the superficial muscles of Quadriceps femoris (vastus medialis (VM), vastus lateralis (VL), rectus femoris (RF).
- Placebo-Group: consisted of 100 subjects (females and males) will receive placebo kinesio taping across quadriceps.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- A Pretest posttest control group
| Arm | Type | Receives |
|---|---|---|
| Cura kinesio-taping | Experimental | Other: Cura Kensio-tapping100 subjects (females and males) will receive kinesio taping from origin to insertion on the superficial muscles of Quadriceps femoris (VM,VL, RF). |
| Placebo | Placebo comparator | Other: placebo100 subjects (females and males) will receive placebo kinesio-taping across quadriceps. |
Who may qualify
- Ages
- 22 to 30 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- Age must be ranged from 22-30 years.
- Body mass index must be ranged from 20-24.9 kg/m².
Key exclusion criteria (5 listed)
- Knee or quadriceps disorders preventing physical stress.
- Cardiovascular or neurological problems.
- Athletic subjects.
- Smokers.
- Heavy caffeine intake subjects.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Cura Kensio-tappingCura tapes, a cotton strip with an acrylic adhesive. allows for unidirectional elasticity up to 60% beyond its resting length. | Other | Cura kinesio-taping |
| placeboplacebo taping | Other | Placebo |
Primary outcome
Peak Torque Measurement 1
Time frame: Before tapping.
The peak torque of quadriceps muscle of dominant lower limb was measured using Biodex system 830-200 Isokinetic dynamometer.
Peak Torque Measurement 2
Time frame: After the application of tapping by 10 minutes
The peak torque of quadriceps muscle of dominant lower limb was measured using Biodex system 830-200 Isokinetic dynamometer.
Peak Torque Measurement 3
Time frame: 24 hours after tapping.
The peak torque of quadriceps muscle of dominant lower limb was measured using Biodex system 830-200 Isokinetic dynamometer.
Peak Torque Measurement 4
Time frame: 72 hours After tapping
The peak torque of quadriceps muscle of dominant lower limb was measured using Biodex system 830-200 Isokinetic dynamometer.
Peak Torque Measurement 5
Time frame: 5 days after removal of tapping b
The peak torque of quadriceps muscle of dominant lower limb was measured using Biodex system 830-200 Isokinetic dynamometer.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Mar 2023.
- Individual participant dataSharing planned: No
Related trials for Quadriceps Muscle Atrophy
Recruiting
Blood Flow Restriction Training in Knee Arthropathy
Knee Arthroscopic Surgery, Arthrogenic Muscle Inhibition
Recruiting
Effects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMA
Spinal Muscular Atrophy (SMA)
RecruitingObservational study
RELATIONSHIP BETWEEN ULTRASONOGRAPHIC QUADRICEPS MUSCLE THICKNESS AND SARCOPENIA MARKERS (HANDGRIP STRENGTH, SARC-F) AND KINESIOPHOBIA IN STROKE PATIENTS
Stroke, Sarcopenia
Not yet recruiting
Effect of Knee Position on Muscle Loss During Leg Immobilization
Muscle Atrophy, Disuse Atrophy
Not yet recruitingObservational study
Muscle Strength Asymmetry In Sarkopenic And Non-sarcopenic Older Adults
Sarcopenia in Elderly
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Cura Kensio-tapping in people with Quadriceps Muscle Atrophy, run by University of Jazan at 1 site in Saudi Arabia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 Mar 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Peak Torque Measurement 1 (time frame: Before tapping.). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Mar 2023.